ENDEXO Trademark

Trademark Overview

On Thursday, April 5, 2007, a trademark application was filed for ENDEXO with the United States Patent and Trademark Office. The USPTO has given the ENDEXO trademark a serial number of 77149896. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, September 1, 2018. This trademark is owned by Interface Biologics Inc.. The ENDEXO trademark is filed in the Chemical Products category with the following description:

Surface modifying fluorinated macromolecules used in medical devices to provide enhanced effects
endexo

General Information

Serial Number77149896
Word MarkENDEXO
Filing DateThursday, April 5, 2007
Status800 - REGISTERED AND RENEWED
Status DateSaturday, September 1, 2018
Registration Number3493379
Registration DateTuesday, August 26, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2007

Trademark Statements

Goods and ServicesSurface modifying fluorinated macromolecules used in medical devices to provide enhanced effects

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, April 10, 2007
Primary Code001
First Use Anywhere DateThursday, March 29, 2007
First Use In Commerce DateThursday, March 29, 2007

Trademark Owner History

Party NameEVONIK CANADA INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBURLINGTON, ONTARIO L7N 3J5
CA
Party NameInterface Biologics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G 1L7
CA
Party NameInterface Biologics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G 1L7
CA
Party NameInterface Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M5V3K2
CA

Trademark Events

Event DateEvent Description
Wednesday, February 26, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, September 1, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, September 1, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, September 1, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, September 1, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 24, 2018TEAS SECTION 8 & 9 RECEIVED
Saturday, August 26, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 10, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, September 10, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, September 10, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 26, 2014TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 26, 2008REGISTERED-PRINCIPAL REGISTER
Wednesday, July 23, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, July 21, 2008ASSIGNED TO LIE
Thursday, July 17, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 7, 2008STATEMENT OF USE PROCESSING COMPLETE
Monday, June 30, 2008USE AMENDMENT FILED
Monday, June 30, 2008TEAS STATEMENT OF USE RECEIVED
Monday, June 30, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 30, 2008TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 1, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2007PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2007NOTICE OF PUBLICATION
Saturday, September 1, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, September 1, 2007ASSIGNED TO LIE
Tuesday, July 24, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 19, 2007ASSIGNED TO EXAMINER
Tuesday, April 10, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

endexo devices provide enhanced effects medical used modifying fluorinated macromolecules surface